Thomas Niel

Thomas Niel

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

7 Unstoppable Growth Stocks to Buy and Hold for the Long Haul

Let it ride with these seven growth stocks to hold, each of which may have what it takes to stay a long-term winner.

Betting on Nikola Stock? Why This EV Rally Could End in Tears.

Nikola stock may keep rallying between now and next month's earnings release, but steering clear may still be your best course of action.

7 Doomed Stocks on a One-Way Trip to Penny Stock Territory

From value traps to busted growth stories, each of these seven doomed penny stocks to sell could soon be a whole lot cheaper.

Why Oracle Stock Could Surge 25% by 2025

Forget about potential downside risk from a possible TikTok ban, there's a path for Oracle stock to rise 25% within a year.

7 REITs to Sell in July Before They Crash & Burn

"Higher for longer" interest rates have stymied a REIT rebound, but even more concerning issues loom with these seven REITs to sell.

Contrarian Tech Plays: 3 Stocks Wall Street Foolishly Abandoned

The market may not be giving these three undervalued tech stocks much notice right now, but don't assume that will remain the case.

7 Cannabis Stocks to Sell in July Before They Crash & Burn

With marijuana still facing legalization limbo, it's high time to bail on these seven cannabis stocks to sell.

Novavax’s Second Act: How a Fallen COVID Star Could Rise from the Ashes

After pulling back following May's "Sanofi surge," don't rule out the potential for further needle-moving news with Novavax stock.

7 ‘Lottery Ticket Stocks’ That Could Turn $1K into $10K

Aggressive investors take note: these seven high-risk. high-reward stocks have the potential to rise in value by as much as 1,000%.

BlackRock Stock Price Target 2025: When Will BLK Hit $1000 per Share?

After years of underperformance, BlackRock stock could start delivering returns on par with its top dog status on Wall Street.